Pretax income is the income that a company earns before paying income taxes. Beximco Pharmaceuticals's pretax income for the
three
months ended in Dec. 2023 was BDT1,849 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was BDT4,381 Mil.
Beximco Pharmaceuticals's pretax margin was 16.96%.
During the past 13 years, Beximco Pharmaceuticals's highest Pretax Margin was 21.62%. The lowest was 14.37%. And the median was 18.73%.
Beximco Pharmaceuticals Pre-Tax Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Beximco Pharmaceuticals's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, Beximco Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beximco Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beximco Pharmaceuticals's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Beximco Pharmaceuticals's Pre-Tax Income falls into.
Beximco Pharmaceuticals Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Beximco Pharmaceuticals's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT4,381 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beximco Pharmaceuticals (DHA:BXPHARMA) Pre-Tax Income Explanation
Beximco Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Beximco Pharmaceuticals's highest Pretax Margin was 21.62%. The lowest was 14.37%. And the median was 18.73%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beximco Pharmaceuticals Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Beximco Pharmaceuticals (DHA:BXPHARMA) Business Description
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DHA:BXPHARMA has been successfully added to your 